Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a heat probe extend life for pancreatic cancer patients?

NCT ID NCT03444948

First seen Apr 23, 2026 · Last updated Jun 18, 2026 · Updated 9 times

Summary

This study tests a procedure called endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for people with inoperable pancreatic cancer. The goal is to see if using a heat probe to destroy tumor tissue can help patients live longer compared to standard medical care alone. The trial involves 108 adults who are fit enough for the procedure, and it measures survival, quality of life, pain, and tumor size.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre de recherche du Centre hospitalier de l'université de Montréal

    Montreal, Quebec, H2X 0A9, Canada

Conditions

The condition(s) this trial relates to.

pancreatic ductal adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.